CDXS
Codexis, Inc.
NASDAQ · Healthcare · Biotechnology · US
$1.44
+1.06%Margins
Gross margin
83.7%
EBITDA margin
-27.8%
EBIT margin
-31.2%
Net margin
-39.6%
FCF margin
-15.7%
-93.2%
Return on equity
-25.6%
Return on assets
-23.0%
Return on invested capital
0.62x
Asset turnover
-$10.4M
Cash from operations
$0.50
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026